Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Minerva Cardiology and Angiology|November 21, 2023
Response to interleukin-1 blockade with anakinra in women and men with ST-segment elevation myocardial infarctionGiuliana Corna, Michele Golino, Azita H Talasaz, et al.Journal of Translational Medicine|June 15, 2022
Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 studyBenjamin Van Tassell, Virginia Mihalick, Georgia Thomas, et al.The American Journal of Cardiology|January 14, 2020
Determinants of Cardiorespiratory Fitness Following Thoracic Radiotherapy in Lung or Breast Cancer SurvivorsJustin M Canada, Cory R Trankle, Salvatore Carbone, et al.The American Journal of Cardiology|September 1, 2021
Preservation of Cardiac Reserve and Cardiorespiratory Fitness in Patients With Acute De Novo Versus Acute on Chronic Heart Failure With Reduced Ejection FractionMarco Giuseppe Del Buono, Virginia Mihalick, Juan Ignacio Damonte, et al.Minerva Cardiology and Angiology|December 5, 2022
Contribution of hemoglobin concentration to cardiorespiratory fitness in black African American patients with recently decompensated heart failure and reduced ejection fractionGeorgia K Thomas, Marco G Del Buono, Juan I Damonte, et al.Current Problems in Cardiology|June 4, 2026
Determinants of Cardiorespiratory Fitness after Successfully Reperfused ST-Elevation Myocardial InfarctionAustin C Hogwood, Krzysztof Smarż, Michele Golino, et al.Cells|May 16, 2023
Change in Eosinophil Count in Patients with Heart Failure Treated with AnakinraMichele Golino, Francesco Moroni, Marco Giuseppe Del Buono, et al.Journal of Cardiovascular Pharmacology|November 25, 2020
Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart FailureGeorge F Wohlford, Benjamin W Van Tassell, Hayley E Billingsley, et al.JACC. Basic to Translational Science|July 6, 2026
Atibuclimab (IC14) for Treatment of Acute Decompensated Heart Failure: A Phase Ib Pilot StudyAntonio Abbate, Michele Golino, Austin C Hogwood, et al.Circulation. Heart Failure|September 13, 2022
Sarcopenic Obesity Is Associated With Reduced Cardiorespiratory Fitness Compared With Nonsarcopenic Obesity in Patients With Heart Failure With Reduced Ejection FractionHayley E Billingsley, Marco Giuseppe Del Buono, Justin M Canada, et al.Pageof 7